Osteoporosis and African American women

Journal of Women's Health and Gender-Based Medicine

Volumn 8, Issue 5, 1999, Pages 609-615

  Bohannon, Arline D ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; ESTROGEN RECEPTOR; VITAMIN D;

ADULT; AGED; BONE ATROPHY; BONE DENSITY; BONE MASS; BONE METABOLISM; BONE MINERAL; CAUCASIAN; DIET SUPPLEMENTATION; DISABILITY; ENVIRONMENTAL FACTOR; FEMALE; FRACTURE; HIP FRACTURE; HORMONE SUBSTITUTION; HUMAN; LIFESTYLE; MENOPAUSE; NEGRO; OSTEOPOROSIS; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; RISK; RISK FACTOR; SMOKING CESSATION; SURVIVAL;

EID: 0032829322     PISSN: 15246094     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.1.1999.8.609     Document Type: Review

References (84)

1. Consensus Development Conference. Prophylaxis and treatment of osteoporosis. Am J Med 1993;94:646.
2. Ray NR, Chan JK, Thaemer M, Melton LJ III. Medical expenditures of osteoporotic fractures in the United States in 1995. Report from the National Osteoporosis Foundation. J Bone Miner Res 1997;12:24.
3. Cooper C, Campion G, Melton LJ III. Hip fractures in the elderly: A world-wide projection. Osteoporosis Int. 1992;2:285.
4. Riggs BL, Melton LJ. The prevention and treatment of osteoporosis. N Engl J Med 1992;327:620.
5. Kellie SE, Brody JA. Sex-specific and race-specific hip fracture rates. Am J Public Health 1990;80:326.
6. Furstenberg AL, Mezey MD. Differences in outcome between black and white elderly hip fracture patients. J Chronic Dis 1987;40:931.
7. Jacobsen SJ, Goldberg J, Miles TP, et al. Race and sex differences in mortality following fracture of the hip. Am J Public Health 1992;82:1147.
8. Buchowski MS, Sun M. Nutrition in minority elders: Current problems and future directions. J Health Care Poor Underserv 1996;7:184.
9. Baron JA, Barrett J, Malenka D, et al. Racial differences in fracture risk. Epidemiology 1994;5:42.
10. Griffin MR, Ray WA, Fought RL, Melton LJ. Blackwhite differences in fracture rates. Am J Epidemiol 1992;136:1378.
11. Karagras MR, Lu-Yao GL, Barrett JA, Beach ML, Baron JA. Heterogeneity of hip fracture: Age, race, sex and geographic patterns of femoral neck and trochanteric fractures among the U.S. elderly. Am J Epidemiol 1996;143:677.
12. Silverman SL, Madison RE. Decreased incidence of hip fracture in Hispanics, Asians and blacks: California hospital discharge data. Am J Public Health 1988; 78:1482.
13. Farmer ME, White LR, Brody JA, Bailey KR. Race and sex differences in hip fracture incidence. Am J Public Health 1984;74:1374.
14. Turner LW, Wang MQ, Fu Q. Risk factors for hip fracture among Southern older women. South Med J 1998;91:533.
15. Meier DE, Luckey MM, Wallenstein S, et al. Calcium, vitamin D, and parathyroid hormone status in young black and white women: Association with racial differences in bone mass. J Clin Endocrinol Metab 1991; 72:703.
16. Meier DE, Luckey MM, Wallenstein S, Lapinski RH, Catherwood B. Racial differences in pre- and post-menopausal bone homeostasis: Association with bone density. J Bone Miner Res 1992;7:1181.
17. Harris SS, Wood MJ, Dawson-Hughes B. Bone mineral density of the total body and forearm in premenopausal black and white women. Bone 1995; 16(4 Suppl):311S.
18. Looker AC, Orwoll ES, Johnston CC Jr, et al. Prevalence of low femoral bone density in older U.S. women from NHANES III. J Bone Miner Res 1995; 10:796.
19. Trotter M, Broman GE, Peterson RR. Densities of bones of white and Negro skeletons. J Bone Joint Surg 1960;42A:50.
20. Gilsanz V, Roe TF, Mora S, Costin G, Goodman WG. Changes in vertebral bone density in black girls and white girls during childhood and puberty. N Engl J Med 1991;325:1597.
21. Bell NH, Shary J, Stevens J, et al. Demonstration that bone mass is greater in black than in white children. J Bone Miner Res 1991;6:719.
22. Bell NH, Yergey AL, Vieira NE, et al. Demonstration of a difference in urinary calcium not calcium absorption in black and white adolescents. J Bone Miner Res 1993;8:1111.
23. Perry HM 3rd, Horowitz M, Morley JE, et al. Aging and bone metabolism in African-American and Caucasian women. J Clin Endocrinol Metab 1996;81:1108.
24. Aloia JF, Vaswani A, Yeh JK, Flaster E. Risk for osteoporosis in black women. Calcif Tissue Int 1996; 59:415.
25. Luckey MM, Wallenstein S, Lapinski R, Meier DE. A prospective study of bone loss in African-American and white women - A clinical research center study. J Clin Endocrinol Metab 1996;81:2948.
26. Luckey MM, Meier DE, Mandeli JP, Da Costa MC, Hubbard ML, Goldsmith SJ. Radial and vertebral bone density in white and black women: Evidence for racial differences in premenopausal bone homeostasis. J Clin Endocrinol Metab 1989;69:762.
27. Parisien M, Cosman F, Morgan D, et al. Histomorphic assessment of bone mass structure and remodeling: A comparison between healthy black and white women. J Bone Miner Res 1997;12:948.
28. Weinstein RS, Bell NH. Diminished rates of bone formation in normal black adults. N Engl J Med 1997;319: 1698.
29. Bell NH, Greene A, Epstein S, et al. Evidence for alteration of the vitamin D-endocrine system in blacks. J Clin Invest 1985;76:470.
30. Cosman F, Morgan DC, Nieves JW, et al. Resistance to bone resorbing effect of PTH in black women. J Bone Miner Res 1997;12:958.
31. Dawson-Hughes B, Harris SS, Finneran S, Rasmussen HM. Calcium absorption responses to calcitriol in black and white premenopausal women. J Clin Endocrinol Metab 1995;80:3068.
32. Cummings SR, Cauley JA, Palermo L, et al. Racial differences in hip axis length may explain racial differences in rates of hip fracture. Osteoporosis Int 1994; 4:226.
33. Wang MC, Aguirre M, Bhudhikanok GS, et al. Bone mass and hip axis length in healthy Asian, black, Hispanic and white American youths. J Bone Miner Res 1997;12:1922.
34. Ralston SH. Genetic markers of bone metabolism and bone disease. Scand J Clin Lab Invest 1997;227(Suppl): 114.
35. Cooper GS, Umbach DM. Are vitamin D receptor polymorphisms associated with bone mineral den3 sity? A meta-analysis. J Bone Miner Res 1996;11:1835.
36. Murray RE, McGuigan F, Grant SF, et al. Polymorphisms of interleukin-6 gene are associated with bone mineral density. Bone 1997;21:89.
37. Langdahl BL, Ralston SH, Grant SF, Eriksen EF. An SpI binding site polymorphism in the COLIA1 gene predicts osteoporotic fractures in both men and women. J Bone Miner Res 1998;13:1384.
38. Fleet JC, Harris SS, Wood RJ, Dawson-Hughes B. The Bsml vitamin D receptor restriction fragment length polymorphism (BB) predicts low bone density in premenopausal black and white women. J Bone Miner Res 1995;10:985.
39. Zmuda JM, Cauley JA, Danielson ME, et al. Vitamin D receptor gene polymorphisms, bone turnover and rates of bone loss in older African-American women. J Bone Miner Res 1997;12:1446.
40. Liel Y, Edwards J, Shary J, Spicer KM, Gordon L, Bell NH. The effects of race and body habitus on bone mineral density of the radius, hip and spine in premenopausal women. J Clin Endocrinol Metab 1988; 66:1247.
41. Kumanyika S, Adams-Campbell LL. Obesity, diet, and psychosocial factors contributing to cardiovascular disease in blacks. Cardiovasc Clin 1991;21:47.
42. Langlois JA, Harris T, Looker AC, Madans J. Weight change between age 50 years and old age is, associated with risk of hip fracture in white women aged 67 and older. Arch Intern Med 1996;156:989.
43. Cauley JA, Gutai JP, Kuller LH, et al. Black-white differences in serum sex hormones and bone mineral density. Am J Epidemiol 1994;124:187.
44. Longcope C, Pratt JH, Scneider SH, et al. Aromatizations of androgens by muscle and adipose tissue. J Clin Endocrinol Metab 1978;46:146.
45. Matkovic V, Ilich JZ, Skugor M, et al. Leptin is inversely related to age at menarche in human females. J Clin Endocrinol Metab 1997;82:3239.
46. Doyle F, Brown J, Lachance C. Relation between bone mass and muscle weight. Lancet 1970;1:391.
47. Bauer DC, Browner WS, Cauley JA, et al. Factors associated with appendicular bone mass in older women. The Study of Osteoporotic Fractures Research Group. Ann Intern Med 1993;118:657.
48. Cummings SR, Kelsey JL, Nevitt MC, O'Dowd KJ. Epidemiology of osteoporosis and osteoporotic fractures. Epidemiol Rev 1985;7:178.
49. Hui SL, Slemenda CW, Johnston CC. Age and bone mass as predictors of fracture in a prospective study. J Clin Invest 1988;81:1804.
50. Cummings S, Nevitt M, Browner W, et al. Risk factors for hip fracture in white women. N Engl J Med 1995;332:767.
51. Grisso JA, Kelsey JL, Strom BL, et al. Risk factors for hip fracture in black women. N Engl J Med 1994; 330:1555.
52. Bohannon AD, Landerman R, Gold D, Hanlon J. Relationships between race, drug use and nonvertebral fractures in community dwelling elderly women. Am J Epidemiol, In press.
53. Cummings SR, Black DM, Nevitt MC, et al. Bone density at various sites for prediction of hip fractures. Lancet 1993;341:72.
54. Blake GM, Patel R, Rymer J, et al. Long-term precision of DXA scanning assessed in forty post-menopausal women followed over seven years. J Bone Miner Res 1997;12:S258.
55. Miller PD, Bonnick SL, Rosen CJ, et al. The clinical utility of bone mass measurements in adults: Consensus of an international panel. Semin Arthritis Rheum 1996;25:361.
56. Miller PD, Bonnick SL, Rosen C. Guidelines for the clinical utilization of bone mass measurement in adult populations. Calcif Tissue Int 1995;57:251.
57. Genant HK, Engelke K, Fuerst T, et al. Noninvasive assessment of bone mineral and structure. State of the art. J Bone Miner Res 1996;11:707.
58. Bales CW, Anderson JJB. Influence of nutritional factors on bone health of the elderly. In: Anderson JJB, Garner SC, eds. Calcium and phosphorus in health and disease. Boca Raton, FL: CRC Press, 1995;319.
59. Quigley MET, Martin PL, Burnier AM, Brooks P. Estrogen therapy arrests bone loss in elderly women. Am J Obstet Gynecol 1987;156:1516.
60. Weiss NS, Ure CL, Ballard JH, et al. Decreased risk of fractures of the hip and lower forearm with post-menopausal use of estrogen. N Engl J Med 1980;303: 1195.
61. Felson DT, Zhang Y, Hannan MT, et al. The effect of postrnenopausal estrogen therapy on bone density in elderly women. N Engl J Med 1993;329:1141.
62. Colditz GA, Hankinson SE, Hunter DJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1996; 332:1589.
63. Hulka BS. Links between hormone replacement therapy and neoplasia. Fertil Steril 1994;62:168S.
64. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiological evidence. Prev Med 1991;20:47.
65. Stanford JC, Weiss NS, Voight LF, et al. Combined estrogen and progestin hormone replacement therapy in relation to breast cancer in middle aged women. JAMA 1995;275:137.
66. Steinberg KK, Smith SJ, Thacker SB, Stroup DF. Breast cancer risk and duration of estrogen use: The role of study design in meta-analysis. Epidemiology 1994;5: 415.
67. Handa V, Landerman LR, Hanlon JT, Harris T, Cohen HJ. Do older women use estrogen replacement? Data from the Duke Established Populations for Epidemiologic Studies of the Elderly (EPESE). J Am Geriatr Soc 1996;44:1.
68. Avioli LV. Calcitonin therapy in osteoporotic syndromes. Rheum Dis Clin North Am 1994;20:777.
69. Liberman UA, Weiss SR, Broll J, et al. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N Engl J Med 1995;333:1437.
70. Black DM, Cummings SR, Karpf DB, et al. Randomized trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 1996;348:1535.
71. Riggs BL, Hodgson SF, O'Fallon M, et al. Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med 1990; 322:802.
72. Pak C, Khashayar S, Damas-Huet B, Piziak V, Peterson R, Poindexter J. Treatment of postmenopausal osteoporosis with slow-release sodium fluoride. Ann Intern Med 1995;123:401.
73. Delmas PD, Bjarnason, Mitlak NH, et al. Effects of raloxifene on bone mineral density, serum cholesterol concentrations and uterine endometrium in postmenopausal women. N Engl J Med 1997;337:1641.
74. Prince RL, Smith M, Dick IM, et al. Prevention of postmenopausal osteoporosis: A comparative study of exercise, calcium supplementation, and hormone replacement therapy. N Engl J Med 1991;325:1189.
75. Chow R, Harrison JE, Notarius C. Effect of two randomized exercise programmes on bone mass of healthy postmenopausal women. Br Med J 1987;295:1441.
76. Kerr D, Morton A, Dick I, et al. Exercise effects on bone mass in postmenopausal women are site-specific and load dependent. J Bone Miner Res 1996;11:218.
77. Nelson ME, Fisher EC, Dilmanian A, et al. A 1-year walking program and increased dietary calcium in postmenopausal women: Effects on bone. Am J Clin Nutr 1991;53:1304.
78. Nelson ME, Fiatarone MA, Morganti CM, et al. Effects of high-intensity strength training on multiple risk factors for osteoporotic fractures: A randomized controlled trial. JAMA 1994;272:1909.
79. Grisso JA, Kelsey JL, Strom BL, et al. Risk factors for falls as a cause of hip fracture in women. N Engl J Med 1991;324:1326.
80. Tinetti ME, Baker DI, McAvay G, et al. A multifactorial intervention to reduce the risk of falling among elderly people living in the community. N Engl J Med 1994;331:821.
81. Cummings SR, Nevitt MC. A hypothesis: The cause of hip fractures. J Gerontol 1989;44:M107.
82. Dargnet-Molina P, Favier F, Grandjean H, et al. Fall-related factors and risk of hip fracture: The EPIDOS prospective study. Lancet 1996;348:145.
83. Pinilla TP, Boardman KC, Bouxsien ML, et al. Impact direction from a fall influences the failure load of the proximal femur as much as age related bone loss. Calcif Tissue Int 1996;58:231.
84. Hanlon JT, Cutson T, Ruby CM. Drug-related falls in the elderly. Top Geriatr Rehabil 1996;11:38.